TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Astimex Pharma AB
Closing information (x1000 SEK)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
73,186
|
53,442
|
39,928 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
33,304
|
19,260
|
11,261 |
EBITDA |
31,910
|
18,646
|
11,323 |
Total assets |
52,579
|
65,239
|
52,925 |
Current assets |
52,460
|
64,967
|
52,719 |
Current liabilities |
11,032
|
7,854
|
7,707 |
Equity capital |
38,291
|
54,129
|
43,046 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
6
![]() |
6
![]() |
6 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
72.8%
|
83.0%
|
81.3% |
Turnover per employee |
12,198
|
8,907
|
6,655 |
Profit as a percentage of turnover |
45.5%
|
36.0%
|
28.2% |
Return on assets (ROA) |
63.3%
|
29.5%
|
21.3% |
Current ratio |
475.5%
|
827.2%
|
684.0% |
Return on equity (ROE) |
87.0%
|
35.6%
|
26.2% |
Change turnover |
19,744
|
13,514
|
1,536 |
Change turnover % |
37%
|
34%
|
4% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.